Terese M. Baker

Part of Woodstream Corp., Zareba Systems, Inc. is a company that manufactures electronic fence controllers, electronic medical instruments, and connectivity products. The company is based in Lititz, PA. Zareba Systems was acquired by Woodstream Corp. on April 01, 2010 for $22.58 million. The company was founded in 1940. The CEO is Miguel A. Nistal.

AMO Development LLC designs, develops and manufactures femtosecond laser technology for use in ophthalmology. It offers Keratoplasty a blade-free laser approach used to incise corneal tissue. The firm's products include metal cone and glass lens for disposable patient interface. The company was founded in 1997 and is headquartered in Irvine, CA.

Metabolon, Inc. operates as a health technology company. It offers precision medicine, clinical diagnostic, and metabolomics services. The firm serves to the pharmaceutical, biotechnology, consumer product industries. The company was founded in 2000 and is headquartered in Morrisville, NC.

ArKal Medical, Inc. develops continuous glucose monitoring (CGM) system. CGM systems measure interstitial fluid glucose and provides continuous readings and information about glucose trends over time. The company was founded by Arvind N. Jina in 2005 and is headquartered in Fremont, CA.

Global Domain Partners LLC provides security and trading services. The firm provides managed services to forecasting companies that uses optimization modeling as a predictive tool for worldwide markets, currencies and commodities. The company was founded by David S. Oros and is located in Baltimore, MD.

Ablative Solutions, Inc. develops and markets endovascular catheters for the treatment of hypertension. It offers solutions for heart failure, kidney disease, metabolic syndrome, and sleep apnea. The company was founded by Tim A. Fischell and David R. Fischell in 2011 and is headquartered in San Jose, CA.

Lifescan, Inc. engages in the development, manufacture, and market of blood glucose monitoring products. Its portfolio includes personal blood glucose meters, testing strips, lancets, point of care testing systems and integrated digital solutions. The company was founded by Gary H. Stroy in 1981 and is headquartered in Wayne, PA.

Camden Partners Private Equity (Camden Partners) is a private equity subsidiary of Camden Partners Holdings LLC founded in 1995 by David Lyle Warnock. The firm is headquartered in Baltimore, Maryland.

Arup Laboratories, Inc. provides clinical and anatomic pathology laboratory services. It offers testing services in the areas of anatomic pathology, pain management, genetics, pediatrics, infectious disease, oncology, and other specialties. The company is headquartered in Salt Lake City, UT.

Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD.

Skyline Vet Pharma, Inc. engages in the manufacture of veterinary pharmaceutical products. The company was founded by Serge R. Martinod and George F. Murphy and is headquartered in Groton, CT.

Neuroone, Inc. operates neurological care centers to treat disorders of the brain and spinal cord. It is a technology platform adds significant value both for payors and patients specifically in the way the company manage treatments for epilepsy, Parkinson’s disease and other neurological disorders. The company was founded in 2016 and is headquartered in Minnetonka, MN.

Mind-X Corp. designs and develops software application. The firm offers MindX. The company was founded by R. Jacob Vogelstein, Julia Brown, and Emily Caporello Bluvas in 2017 and is headquartered in Bethesda, MD.

Gigantum, Inc. provides computer software. It offers data science, docker, jupyter and python. The company was founded by Tyler J. Whitehouse, Dean Kleissas, Jacob R. Vogelstein, Randal Burns and Joshua Vogelstein and is headquartered in Washington, DC.

Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York.

Amplifica Holdings Group, Inc. is a biopharmaceutical company based in San Diego, CA. Amplifica is focused on developing novel treatments for androgenic alopecia, a condition that affects millions of men and women. The company is taking a nature-inspired scientific approach to regrow natural hair by identifying and isolating unique signaling molecules that stimulate hair follicles. Amplifica is dedicated to developing novel therapeutics for hair regrowth. The company was founded by William Rassman, Maksim Plikus, Wajdie Ahmad, and the CEO is Frank M. Fazio.

Part of Quest Diagnostics, Inc., Haystack Oncology, Inc. is a biopharmaceutical company based in Baltimore, MD. The Haystack MRD test is CLIA certified in the US and is available for biopharmaceutical clinical development in laboratories located in various locations. The company developed Haystack MRD™, a next-generation tumor-informed approach for the measurement of minimal residual disease. Haystack Oncology works with biopharmaceutical companies to advance important therapeutics to markets, from early phase clinical development to companion diagnostics. The test accelerates clinical development with better MRD testing unmatched sensitivity and specificity for confident MRD detection. The company leverages unmatched sensitivity and specificity to accelerate clinical trials and produce insights that drive biopharma pipeline development. The company was founded in 2021 by Kenneth W. Kinzler, Nickolas Papadopoulos, Joshua Cohen, Bert Vogelstein, and the CEO is Dan Edelstein. Haystack Oncology was acquired by Quest Diagnostics, Inc. on June 21, 2023 for $450 million.

Catalio Capital Management LP (Investment Management) (Catalio-IM) is the hedge fund management division of Catalio Capital Management LP, a venture capital firm headquartered in New York City. The firm was founded in 2020 by George Petrocheilos and R. Jacob Vogelstein. Catalio-IM serves as an investment manager and provides discretionary investment management services to several privately offered investment funds and vehicles that are generally open to, among others, institutions, pension plans, endowments, high net-worth individuals, financially sophisticated individuals, and other qualified investors.